Started in 1934 by Arthur Sudler & Matthew Hennessey, Sudler & Hennessey (S&H) was acquired by Young & Rubicam in the USA during the 70s. By that time, S&H had acquired the reputation of being the best in healthcare communications. Its expansion beyond the USA continued. The ‘Manny Award’ won for the ‘Best Global Agency Network’ in 2005 best depicts its global presence.

Sudler & Hennessey India started in November 2002 is a joint venture partnership between WPP and Rediffusion Dentsu Young & Rubicam. Sudler & Hennessey has been structured to suit the requirements of the Indian Pharmaceutical Industry - in terms of the talent and the services offered. Its Professional Solutions (Rx Division), Consumer Division (Direct to Consumer), IntraMed (Scientific Communication for doctors), Interactive Division (For loyalty programmes and multimedia solutions) and Avenue-e (Internet communications consulting, technology and digital media) together make it a multifaceted healthcare communications company that offers a truly integrated approach.

Over the years, Sudler & Hennessey India has acquired a strong portfolio of businesses like Dr. Reddy's Labs, GlaxoSmithKline, Ranbaxy, Novo Nordisk, Indigene Lifesciences, PSI, Merck Oncology and Johnson & Johnson's Ethicon Endosurgery. It has also worked on Nicholas Piramal India Ltd., Galderma, RPG, Cipla and Pfizer. Its objective is to partner its clients in providing communication solutions that are relevant to the brand/category.

Sudler & Hennessey proved its mettle internationally by sweeping The Rx Club Awards, New York by walking away with 2 Gold, 1 Silver and 12 Awards of Excellence! Last year too, it won 1 Silver and 2 Awards of Excellence.

Sudler & Hennessey India currently caters to its clients through its offices at Mumbai and Bangalore.